InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
0.00%
)
US TECH 100
19,426.00
(
-0.23%
)
Dow Jones
42,313.00
(
0.00%
)
Brent Oil
71.34
(
-0.52%
)
Bitcoin
64,032.54
(
-2.43%
)
Post# of 253253
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 110601

Thursday, 12/09/2010 8:53:44 PM

Thursday, December 09, 2010 8:53:44 PM

Post# of 253253
Some IRB’s take a dim view of sham infusions.

I agree with your last statement; now that Gilenya is approved, new oral agents will presumably be tested head-to-head vs Gilinya, and new injectable agents can continue to be tested head-to-head vs any of several comparators.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up